Evidence map›Paper›PMID 25281661›Full record

ArticleHuman molecular genetics2015

Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.

Koichi Matsuda, Atsushi Takahashi, Candace D Middlebrooks, Wataru Obara, Yasutomo Nasu, Keiji Inoue, Kenji Tamura, Ichiro Yamasaki, Yoshio Naya, Chizu Tanikawa and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Sickle Cell Anemia: Variants in theFrontiers in pharmacology · 2020
    Article
  18. Genome-Wide Association Studies of Cancer in Diverse Populations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  19. SLC14A1: a novel target for human urothelial cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 17 institutions in 2 countries.

Koichi MatsudaLaboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Atsushi TakahashiCenter for Integrative Medical Science, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan.
Candace D MiddlebrooksDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Wataru ObaraDepartment of Urology, Iwate Medical University School of Medicine, Iwate, Japan.
Yasutomo NasuDepartment of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Keiji InoueDepartment of Urology, School of Medicine, Kochi University, Koichi, Japan.
Kenji TamuraDepartment of Urology, School of Medicine, Kochi University, Koichi, Japan.
Ichiro YamasakiDepartment of Urology, School of Medicine, Kochi University, Koichi, Japan.
Yoshio NayaDepartment of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Chizu TanikawaLaboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Ri CuiLaboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Jonine D FigueroaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Debra T SilvermanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Mikio NamikiDepartment of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan.
Yoshihiko TomitaDepartment of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Hiroyuki NishiyamaDepartment of Urology, Faculty of Medicine, University of Tsukuba, Ibaragi, Japan.
Kenjiro KohriDepartment of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.
Takashi DeguchiDepartment of Urology, Graduate School of Medicine, Gifu University, Gifu, Japan.
Masayuki NakagawaDepartment of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Masayoshi YokoyamaDepartment of Urology, Ehime University Graduate School of Medicine, Ehime, Japan.
Tsuneharu MikiDepartment of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hiromi KumonDepartment of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Tomoaki FujiokaDepartment of Urology, Iwate Medical University School of Medicine, Iwate, Japan.
Ludmila Prokunina-OlssonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
Michiaki KuboCenter for Integrative Medical Science, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan.
Yusuke NakamuraDepartment of Medicine and Department of Surgery, Center for Personalized Therapeutics, The University of Chicago, Chicago, IL, USA ynakamura@bsd.uchicago.edu.
Taro ShuinDepartment of Urology, School of Medicine, Kochi University, Koichi, Japan.
Kōchi University · JPNational Cancer Institute · USThe University of Tokyo · JPIwate Medical University · JPKyoto Prefectural University of Medicine · JPNational Institutes of Health · USOkayama University · JPEhime University · JPGifu University · JPKagoshima University · JPKanazawa University · JPNagoya City University · JPRIKEN · JPRIKEN Center for Integrative Medical Sciences · JPUniversity of Chicago · USUniversity of Tsukuba · JPYamagata University · JP

Funding

Cancer Genetic Markers of SusceptibilityZIACP010187 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI CHANOCK, STEPHEN J. · 2009 to 2025
$4.7M
6 · The paper itself

Abstract

Through genome-wide association analysis and an independent replication study using a total of 1131 bladder cancer cases and 12 558 non-cancer controls of Japanese populations, we identified a susceptibility locus on chromosome 15q24. SNP rs11543198 was associated with bladder cancer risk with odds ratio (OR) of 1.41 and P-value of 4.03 × 10(-9). Subgroup analysis revealed rs11543198 to have a stronger effect in male smokers with OR of 1.66. SNP rs8041357, which is in complete linkage disequilibrium (r(2) = 1) with rs11543198, was also associated with bladder cancer risk in Europeans (P = 0.045 for an additive and P = 0.025 for a recessive model), despite much lower minor allele frequency in Europeans (3.7%) compared with the Japanese (22.2%). Imputational analysis in this region suggested CYP1A2, which metabolizes tobacco-derived carcinogen, as a causative candidate gene. We also confirmed the association of previously reported loci, namely SLC14A1, APOBEC3A, PSCA and MYC, with bladder cancer. Our finding implies the crucial roles of genetic variations on the chemically associated development of bladder cancer.

Indexed as

Chromosomes, Human, Pair 15Genetic Predisposition to DiseaseGenome-Wide Association StudyPolymorphism, Single NucleotideAllelesAsian PeopleCase-Control StudiesFemaleGenetic Association StudiesGenotypeHumansJapanMaleOdds RatioReproducibility of ResultsSmoking

Identifiers

PMID25281661
PMCPMC4834880
OpenAlexW2153267766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.